Forte Biosciences FBRX Stock
$16.69
-1.823526%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$341.79M
LOW - HIGH [24H]
$16.41
-
$17.40
VOLUME [24H]
$272.85K
P/E Ratio
0
Earnings per share
-$4.58
ISIN
US34962G2084
Forte Biosciences Price Chart
Forte Biosciences FBRX Financial and Trading Overview
| Forte Biosciences stock price | 16.69 USD |
| Previous Close | 19.07 USD |
| Open | 19.3 USD |
| Bid | 14.64 USD x 200 |
| Ask | 24.47 USD x 200 |
| Day's Range | 18.75 - 20.66 USD |
| 52 Week Range | 7.78 - 35.8 USD |
| Volume | 354.69K USD |
| Avg. Volume | 282.18K USD |
| Market Cap | 394.01M USD |
| Beta (5Y Monthly) | 3.005 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.58 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 63.75 USD |
FBRX Valuation Measures
| Enterprise Value | 407.77M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.6450987 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.3582287 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.302 |
Trading Information
Forte Biosciences Stock Price History
| Beta (5Y Monthly) | 3.005 |
| 52-Week Change | 115.96% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 35.8 USD |
| 52 Week Low | 7.78 USD |
| 50-Day Moving Average | 26.41 USD |
| 200-Day Moving Average | 21.9 USD |
FBRX Share Statistics
| Avg. Volume (3 month) | 282.18K USD |
| Avg. Daily Volume (10-Days) | 221.38K USD |
| Shares Outstanding | 20.48M |
| Float | 18.83M |
| Short Ratio | 5.37 |
| % Held by Insiders | 2.14% |
| % Held by Institutions | 70.54% |
| Shares Short | 1.21M |
| Short % of Float | 5.91% |
| Short % of Shares Outstanding | 5.88% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -83.89% |
| Return on Equity (ttm) | -188.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -76902000 USD |
| Net Income Avi to Common (ttm) | -75855000 USD |
| Diluted EPS (ttm) | -4.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 58.22M USD |
| Total Cash Per Share (mrq) | 2.38 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.753 |
| Book Value Per Share (mrq) | 3.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -59335000 USD |
| Levered Free Cash Flow (ttm) | -31247500 USD |
Profile of Forte Biosciences
| Country | United States |
| State | TX |
| City | Dallas |
| Address | 3060 Pegasus Park Drive |
| ZIP | 75247 |
| Phone | 310 618 6994 |
| Website | https://www.fortebiorx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Q&A For Forte Biosciences Stock
What is a current FBRX stock price?
Forte Biosciences FBRX stock price today per share is 16.69 USD.
How to purchase Forte Biosciences stock?
You can buy FBRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Forte Biosciences?
The stock symbol or ticker of Forte Biosciences is FBRX.
Which industry does the Forte Biosciences company belong to?
The Forte Biosciences industry is Biotechnology.
How many shares does Forte Biosciences have in circulation?
The max supply of Forte Biosciences shares is 20.48M.
What is Forte Biosciences Price to Earnings Ratio (PE Ratio)?
Forte Biosciences PE Ratio is now.
What was Forte Biosciences earnings per share over the trailing 12 months (TTM)?
Forte Biosciences EPS is -4.58 USD over the trailing 12 months.
Which sector does the Forte Biosciences company belong to?
The Forte Biosciences sector is Healthcare.
Forte Biosciences FBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26830.96 USD — |
-0.09
|
7.73B USD — | 26554.24 USD — | 26923.7 USD — | — - | 7.73B USD — |
| US Tech Health Care IXHC | 1158.02 USD — |
+2.16
|
— — | 1146.48 USD — | 1165.81 USD — | — - | — — |
- {{ link.label }} {{link}}